New Delhi, Sept. 26 -- Americans will be the first to be affected, said Niranjan Hiranandani, Founder and Chairman of the Hiranandani Group on Friday, in response to U.S. President Donald J. Trump's announcement of a 100 per cent tariff on branded and patented pharmaceutical products.

Speaking exclusively to ANI, Hiranandani said, "First of all, you have to understand the Americans will be impacted first. So if you are putting tax on medicines, the medicines will become more expensive in America. So I think America will be the first to be affected. Yes, we will be affected because we do sales to America. We sell steel, we sell other equipment, we sell pharmaceuticals, all these things. So the companies which are doing this business will ...